Skip to main content
    L

    Larimar Therapeutics Inc (LRMR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.99
    -0.01 (-0.33%)

    Market Cap: $311.65M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Larimar Therapeutics Inc (LRMR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Larimar Therapeutics (LRMR) has a latest price of $2.99 on Nov 17, 2026, 53.4% below its 52-week high of $6.42. Its price fell 11.5% over the past 12 months. The month-end price fell 93.2% over the 10 years through Oct 2026, a compound annual decline of 23.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $140.34 in Sep 2018 and its lowest $1.79 in Jul 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart LRMR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LRMR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 29.6%, and over 6 months it fell 10.2%. The month-end price fell 15.7% over the 3 years through Oct 2026, a compound annual decline of 5.5%.

    PeriodChange
    1 month+41.0%
    3 months-29.6%
    6 months-10.2%
    12 months-11.5%
    12 months, with dividends-11.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-15.7%-5.5%
    5 years-79.3%-27.0%
    10 years-93.2%-23.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 60.7%, and its weakest was 2019, when it fell 77.6%.

    YearCloseChange
    2026 through Oct 2026$2.47-35.2%
    2025$3.81-1.6%
    2024$3.87-14.9%
    2023$4.55+10.2%
    2022$4.13-61.7%
    2021$10.79-49.6%
    2020$21.41+60.7%
    2019$13.33-77.6%
    2018$59.42+7.1%
    2017$55.46+45.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 3.3% above its 50-day average of $2.90 and 20.5% below its 200-day average of $3.76.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.99
    52-week high$6.42-53.4%
    52-week low$1.92+56.1%
    50-day average$2.90+3.3%
    200-day average$3.76-20.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 87.1%.

    MeasureValue
    1-year beta1.91
    Largest fall, 1 year-66.6%
    Largest fall, 3 years-87.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About LRMR

    What is LRMR's 1-year price change?

    Larimar Therapeutics's price fell 11.5% over the past 12 months. With dividends included, the 12-month total return was -11.5%.

    What is LRMR's 5-year price change?

    Larimar Therapeutics's month-end price fell 79.3% over the 5 years through Oct 2026, a compound annual decline of 27.0%. These figures leave out dividends.

    What is LRMR's 52-week high and low?

    Larimar Therapeutics's 52-week high is $6.42 and its 52-week low is $1.92. Its latest price of $2.99 on Nov 17, 2026 is 53.4% below the high.

    What is LRMR's beta?

    Larimar Therapeutics's 1-year beta against the S&P 500 is 1.91, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 66.6%.

    Is the LRMR chart free?

    Yes. Advanced Charting for LRMR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.